Armen Shanafelt - Insider Trading & Ownership

Location
C/O Lilly Ventures Fund I, Llc, 115 W. Washington Street,Ste 1680 South, Indianapolis, IN
Summary
The estimated net worth of Armen Shanafelt is at least $84.1K dollars as of June 10, 2022. Armen Shanafelt is the Director of Aeglea BioTherapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $84.1K.
Signature
/s/ Jessica Fees, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Armen Shanafelt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. Director $84.1K Jun 7, 2022
SURF Surface Oncology, Inc. Director, 10%+ Owner Jun 8, 2022

Insider Transactions Reported by Armen Shanafelt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.